To determine the role of Tregs in the immunomodulation caused by rBmaCys treatment in DSS-induced colitis mice, we analyzed the percent frequency of CD3+CD4+CD25+FoxP3+ Tregs in the colon, spleen, and mesenteric lymph nodes (MLNs). This evidence concerns the gene CD4 and colitis.